Bestim / SCV-07 / Golotimod
6 indexed publications · 3 human studies · 4 registered trials · research from 2003 to 2011
Research goals studied
- Cancer & oncology
- Immune function
- Infection & antiviral
Studies referencing Bestim / SCV-07 / Golotimod
Bayesian Network Predictors of Severe Oral Mucositis in an SCV-07 Clinical Trial
2011 · Human evidence
Predictive-model analysis using data from an SCV-07 oral-mucositis trial.
SCV-07 for Prevention of Severe Oral Mucositis During Chemoradiation
2010 · Human evidence
Clinical trial report evaluating SCV-07 for chemoradiation-associated oral mucositis.
SCV-07 in Recurrent Genital Herpes Simplex Virus Type 2 Infection
2008 · Human evidence
Clinical evaluation of SCV-07 in recurrent genital HSV-2 infection.
SCV-07 (SciClone Pharmaceuticals/Verta)
2006 · Preclinical
Drug-development profile summarizing SCV-07 pharmacology and clinical programs.
Enzymatic Production of the Immunomodulatory Dipeptide SCV-07
2004 · Preclinical
Described enzymatic synthesis/production of SCV-07.
Biological Activity of Peptide SCV-07 Against Murine Tuberculosis
2003 · Preclinical
Evaluated SCV-07 in a murine tuberculosis model.
Working with Bestim / SCV-07 / Golotimod?
Convert a vial to draw volume on the peptide calculator, or track protocols and vials in the free app.
Start tracking free